Congressional Republicans are enthusiastically doubling down on the corruption openings five Republicans on the Supreme Court ...

Nvidia has been the hottest stock since the start of the AI revolution, and I see one particular healthcare business ...

New drug discovery is extremely inefficient. Estimates of the average R&D cost per new drug are less than $1 billion to more ...

A new Lancet study forecast what may happen over the next 25 years if more isn't done to address antimicrobial resistant ...

This is thanks to Lilly's dominance in the billion-dollar weight loss drug market. Lilly's Mounjaro and Zepbound have helped ...

Boston, MA – The much-anticipated RE•WORK AI in Healthcare & Pharma Summit is set to take place on November 13-14, 2024, at ...

Three years ago, the cigarette giant acquired Vectura, a British pharmaceutical firm that makes asthma inhalers, raising ...

Indian shares are set to open higher on Tuesday, tracking a rebound in global stocks ahead of the key U.S. inflation data and ...

The U.S. House of Representatives has passed the Biosecure Act to limit business with Chinese biotech companies on national ...

Liver herbal supplement Liv 52 emerged as one of India's top-selling herbal tonics in August, driven by increased cases of liver-related illnesses during the monsoon season. The Indian pharmaceutical ...

Hoping to skirt the slow pace of new drug development, researchers are leaning on AI to uncover fresh uses for known ...

As more drugs approach late-stage development for PAH, Cereno Scientific’s CEO expects more successful disease-modifying ...